Bright Minds Biosciences (DRUG) Return on Equity (2023 - 2025)
Bright Minds Biosciences (DRUG) reported Return on Equity of 0.0% for Q3 2025, little changed on a YoY basis from 0.0% in Q3 2024, and down 17.42% quarter-over-quarter from 0.0% in Q2 2025.
Bright Minds Biosciences (DRUG) Return on Equity (2023 - 2025) Analysis & Trends
Bright Minds Biosciences has reported Return on Equity for 3 years, with the latest figure at 0.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -0.81% |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -0.04% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -0.01% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.01% |
| 10 | Bright Minds Biosciences | 16.28 Bn | 16.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |